KEYNOTE-A18 / ENGOT-cx11

Name No. For Patients with Purpose
KEYNOTE-A18 / ENGOT-cx11 21-03

High-Risk Locally advanced cervical carcinoma

To compare the use of Chemoradiotherapy with or without Pembrolizumab for the treatment of High-risk Locally Advanced Cervical Cancer